1.41
price down icon2.76%   -0.04
after-market アフターアワーズ: 1.49 0.08 +5.67%
loading
前日終値:
$1.45
開ける:
$1.46
24時間の取引高:
313.22K
Relative Volume:
0.74
時価総額:
$76.79M
収益:
-
当期純損益:
$-40.56M
株価収益率:
-1.2051
EPS:
-1.17
ネットキャッシュフロー:
$-35.28M
1週間 パフォーマンス:
-12.96%
1か月 パフォーマンス:
-1.40%
6か月 パフォーマンス:
-17.54%
1年 パフォーマンス:
-53.16%
1日の値動き範囲:
Value
$1.39
$1.47
1週間の範囲:
Value
$1.39
$1.66
52週間の値動き範囲:
Value
$0.8505
$4.42

Pds Biotechnology Corporation Stock (PDSB) Company Profile

Name
名前
Pds Biotechnology Corporation
Name
セクター
Healthcare (1174)
Name
電話
800-208-3343
Name
住所
303A COLLEGE ROAD EAST, PRINCETON
Name
職員
24
Name
Twitter
@pdsbiotech
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
PDSB's Discussions on Twitter

PDSB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PDSB
Pds Biotechnology Corporation
1.41 76.79M 0 -40.56M -35.28M -1.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Pds Biotechnology Corporation Stock (PDSB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-11-01 開始されました B. Riley Securities Buy
2021-06-28 開始されました Cantor Fitzgerald Overweight
2020-11-10 アップグレード H.C. Wainwright Neutral → Buy
2020-05-27 開始されました Alliance Global Partners Buy
2020-03-09 開始されました Noble Capital Markets Outperform
2019-10-24 開始されました Chardan Capital Markets Buy
すべてを表示

Pds Biotechnology Corporation (PDSB) 最新ニュース

pulisher
Jun 18, 2025

PDSB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Jun 18, 2025
pulisher
Jun 17, 2025

Transcript : PDS Biotechnology CorporationSpecial Call - MarketScreener

Jun 17, 2025
pulisher
Jun 14, 2025

PDS Biotechnology (NASDAQ:PDSB) Stock Rating Lowered by Wall Street Zen - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

HC Wainwright Issues Pessimistic Estimate for PDSB Earnings - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

PDS Biotechnology Co. (NASDAQ:PDSB) Shares Sold by Millennium Management LLC - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Raises Stock Holdings in PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

PDS Biotechnology (NASDAQ:PDSB) Receives Buy Rating from HC Wainwright - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

PDS Biotech expands equity incentive plan By Investing.com - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

PDS Biotech expands equity incentive plan - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

PDS Biotechnology Approves Equity Plan Amendment at Meeting - TipRanks

Jun 11, 2025
pulisher
Jun 11, 2025

# H.C. Wainwright maintains Buy rating on PDS BIOTECHNOLOGY stock - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

# H.C. Wainwright maintains Buy rating on PDS BIOTECHNOLOGY stock By Investing.com - Investing.com UK

Jun 11, 2025
pulisher
Jun 09, 2025

PDSB Biotechnology's Virtual Event to Discuss Advances in HPV16-Positive HNSCC | PDSB Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

PDS Biotech to Host Key Opinion Leader Event to Discuss Versamune® HPV for the Treatment of HPV16+ HNSCC - The Manila Times

Jun 09, 2025
pulisher
Jun 09, 2025

PDS Biotechnology Corporation to Host Webinar on HPV16-Positive HNSCC and Merck KN-689 Study - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Invests $58,000 in PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

Jun 09, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Trims Stock Holdings in PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

PDS Biotech reports steady survival rates in HPV16-positive HNSCC trial By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 02, 2025

2 Biopharmaceutical Stocks Focused on Cancer That Wall Street Predicts Will More Than Double - inkl

Jun 02, 2025
pulisher
Jun 02, 2025

Take the Zacks Approach to Beat the Markets: StoneCo, Axon, Intuit in Focus - TradingView

Jun 02, 2025
pulisher
Jun 02, 2025

PDSB: PDS Biotechnology Releases Promising Results from Versamune HPV Studies | PDSB Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

PDS Biotechnology Publishes Versamune® HPV Abstracts at ASCO - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

PDS Biotech reports steady survival rates in HPV16-positive HNSCC trial - Investing.com India

Jun 02, 2025
pulisher
Jun 02, 2025

Clinical Trial Breakthrough: PDS Biotech Achieves 30-Month Survival in Advanced Head and Neck Cancer Patients - Stock Titan

Jun 02, 2025
pulisher
May 28, 2025

PDS Biotechnology files to sell 9.82M shares of common stock for holders - MSN

May 28, 2025
pulisher
May 28, 2025

PDS Biotechnology (PDSB) Announces Plan to Offer 9.82 Million Sh - GuruFocus

May 28, 2025
pulisher
May 27, 2025

PDS Biotechnology (PDSB) Plans Sale of 9.82 Million Shares | PDS - GuruFocus

May 27, 2025
pulisher
May 27, 2025

PDS Biotechnology (PDSB) Announces Plan to Offer 9.82 Million Shares - GuruFocus

May 27, 2025
pulisher
May 27, 2025

PDS Biotechnology (PDSB) Plans Sale of 9.82 Million Shares | PDSB Stock News - GuruFocus

May 27, 2025
pulisher
May 24, 2025

Wall Street Zen Upgrades PDS Biotechnology (NASDAQ:PDSB) to “Hold” - Defense World

May 24, 2025
pulisher
May 23, 2025

PDS Biotechnology Corporation (PDSB)’s Versamune HPV Surpasses Survival Benchmarks in Recurrent Head and Neck Cancer Trial - Insider Monkey

May 23, 2025
pulisher
May 23, 2025

Q2 EPS Estimates for PDS Biotechnology Raised by B. Riley - Defense World

May 23, 2025
pulisher
May 23, 2025

PDS Biotech reports extended survival in HPV cancer study - Investing.com Australia

May 23, 2025
pulisher
May 22, 2025

PDS Biotech reports extended survival in HPV cancer study By Investing.com - Investing.com India

May 22, 2025
pulisher
May 22, 2025

PDS Biotechnology Reports Promising Overall Survival Data for Versamune® HPV Combined with Pembrolizumab in HPV16-Positive Head and Neck Cancer - Nasdaq

May 22, 2025
pulisher
May 22, 2025

PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Evaluating Versamune® HPV to be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - TradingView

May 22, 2025
pulisher
May 22, 2025

PDS Biotech at A.G.P. Showcase: Versamune’s Promising Potential By Investing.com - Investing.com South Africa

May 22, 2025
pulisher
May 21, 2025

PDS Biotech at A.G.P. Showcase: Versamune’s Promising Potential - Investing.com

May 21, 2025
pulisher
May 20, 2025

PDS Biotech to Participate at the A.G.P. Virtual Annual Healthcare Company Showcase - The Manila Times

May 20, 2025
pulisher
May 17, 2025

PDS Biotechnology Corporation (NASDAQ:PDSB) Q1 2025 Earnings Call Transcript - MSN

May 17, 2025
pulisher
May 16, 2025

PDS Biotech outlines continued VERSATILE 003 Phase 3 expansion while advancing HPV16-positive head and neck cancer strategy - MSN

May 16, 2025
pulisher
May 15, 2025

Raymond James Financial Inc. Takes $26,000 Position in PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

May 15, 2025
pulisher
May 15, 2025

PDS Biotechnology Corp (PDSB) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

PDS Biotechnology Reports Q1 2025 Progress and Financials - TipRanks

May 15, 2025
pulisher
May 14, 2025

PDS Biotech advances Phase 3 trial, reports Q1 financials By Investing.com - Investing.com Nigeria

May 14, 2025
pulisher
May 14, 2025

PDS Biotechnology: Q1 Earnings Snapshot - Midland Daily News

May 14, 2025
pulisher
May 14, 2025

EMV Capital portfolio company PDS Biotech advances cancer trial - Proactive Investors

May 14, 2025
pulisher
May 14, 2025

PDS Biotech advances Phase 3 trial, reports Q1 financials - Investing.com Australia

May 14, 2025
pulisher
May 14, 2025

Earnings call transcript: PDS Biotech’s Q1 2025 results show reduced losses - Investing.com

May 14, 2025
pulisher
May 14, 2025

Transcript : PDS Biotechnology Corporation, Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com

May 14, 2025

Pds Biotechnology Corporation (PDSB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Pds Biotechnology Corporation (PDSB) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Glover Stephen C.
Director
Feb 28 '25
Buy
1.66
15,061
25,001
78,851
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
大文字化:     |  ボリューム (24 時間):